126 related articles for article (PubMed ID: 2236164)
1. Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience.
Peters WP
Prog Clin Biol Res; 1990; 354B():185-94. PubMed ID: 2236164
[No Abstract] [Full Text] [Related]
2. A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.
Ayash LJ; Antman K; Cheson BD
Oncology (Williston Park); 1991 Mar; 5(3):25-33; discussion 33, 36, 41. PubMed ID: 1829944
[TBL] [Abstract][Full Text] [Related]
3. Dose intensity studies in breast cancer--autologous bone marrow transplantation.
Hortobagyi GN; Dunphy F; Buzdar AU; Spitzer G
Prog Clin Biol Res; 1990; 354B():195-209. PubMed ID: 2236166
[No Abstract] [Full Text] [Related]
4. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
[TBL] [Abstract][Full Text] [Related]
5. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
Eder JP; Antman K; Peters W; Henner WD; Elias A; Shea T; Schryber S; Andersen J; Come S; Schnipper L
J Clin Oncol; 1986 Nov; 4(11):1592-7. PubMed ID: 3534155
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.
Mulder NH; Dolsma WV; Mulder PO; De Vries EG; Willemse PH; Sleijfer DT; Hospers GA; Van der Graaf WT
Anticancer Res; 1995; 15(4):1565-8. PubMed ID: 7654046
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.
Tallman MS; Rademaker AW; Jahnke L; Brown SG; Bauman A; Mangan C; Kelly C; Rubin H; Kies MS; Shaw J; Kiel K; Gordon LI; Gradishar WJ; Winter JN
Bone Marrow Transplant; 1997 Nov; 20(9):721-9. PubMed ID: 9384473
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
Myers SE; Mick R; Williams SF
Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
[TBL] [Abstract][Full Text] [Related]
9. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes.
Lalisang RI; Hupperets PS; ten Haaft MA; Jansen RL; Schouten HC
Bone Marrow Transplant; 1998 Feb; 21(3):243-7. PubMed ID: 9489646
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
13. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
Maraninchi D; Droz JP
Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
Peters WP
Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
[No Abstract] [Full Text] [Related]
15. High-dose chemotherapy with bone marrow support for solid tumors.
Antman K; Eder JP; Frei E
Important Adv Oncol; 1987; ():221-35. PubMed ID: 2841230
[No Abstract] [Full Text] [Related]
16. High-dose chemotherapy and autologous bone marrow support for breast cancer.
Peters WP
Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274
[No Abstract] [Full Text] [Related]
17. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
18. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
20. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]